home / stock / ebs / ebs news


EBS News and Press, Emergent Biosolutions Inc. From 07/09/24

Stock Information

Company Name: Emergent Biosolutions Inc.
Stock Symbol: EBS
Market: NYSE
Website: emergentbiosolutions.com

Menu

EBS EBS Quote EBS Short EBS News EBS Articles EBS Message Board
Get EBS Alerts

News, Short Squeeze, Breakout and More Instantly...

EBS - Emergent, J&J resolve dispute over COVID vaccine manufacturing deal

2024-07-09 06:00:29 ET Emergent BioSolutions ( NYSE: EBS ) and Johnson & Johnson ( NYSE: JNJ ) have reached a settlement agreement to resolve all claims related to a now-terminated manufacturing services deal for the latter's COVID-19 vaccine.... Read the full ...

EBS - Update: Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products

GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received more than $250 million in contract modifications from the Administration for Strategic Preparedness and Response (ASPR) at the United States Department of Health and Human S...

EBS - Emergent BioSolutions secures $250M contracts for the U.S. government

2024-07-02 08:31:31 ET More on Emergent Biosolutions Emergent BioSolutions: High-Risk, High-Reward Strategic Turnaround Emergent BioSolutions Inc. (EBS) Q1 2024 Earnings Call Transcript Emergent BioSolutions Inc. 2024 Q1 - Results - Earnings Call Presentation ...

EBS - Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products

GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received more than $250 million in contract modifications from the Administration for Strategic Preparedness and Response (ASPR) at the United States Department of Health and Human S...

EBS - 7 Top Stocks Under $10: June 2024 Edition

2024-06-24 06:35:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips While blue chip stocks are always a good investment portfolio idea, I suggest some smart diversification. And one of the best ways that I know to diversify is to buy highly rated stocks und...

EBS - Emergent to sell Baltimore-Camden production site for $30M

2024-06-20 09:26:46 ET More on Emergent Biosolutions Emergent BioSolutions: High-Risk, High-Reward Strategic Turnaround Emergent BioSolutions Inc. (EBS) Q1 2024 Earnings Call Transcript Emergent BioSolutions Inc. 2024 Q1 - Results - Earnings Call Presentation ...

EBS - Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 Million

GAITHERSBURG, Md., June 20, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has entered into a definitive agreement to sell its drug product facility in Baltimore-Camden to an affiliate of Bora Pharmaceuticals Co., Ltd. (“Bora”, TWSE: 6472), a...

EBS - Trading (EBS) With Integrated Risk Controls

2024-06-17 16:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

EBS - (EBS) Investment Analysis

2024-06-08 01:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

EBS - Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic & Recognizes National Naloxone Awareness Day

Naloxone is a medication that rapidly reverses the effects of opioid overdose and is the standard of care for opioid overdose reversal in a community setting New topline survey findings reinforce the need for continued education on naloxone GAITHERSBURG, Md., June 06, 2024 (GLOBE ...

Previous 10 Next 10